Governance
Investors
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dodekin
Dekavil
ABBV-022
Onco IX
OncoFAP
FAP-IL12
Tripokin
Press Releases & Events
Work with us
Careers
Partnering
About us
Profile
Management
Board
Scientific Advisory Board
Our Science
Strategy
Enabling Technologies
Product Classes
Pipeline
Pipeline
Nidlegy
TM
Fibromun
Darleukin
Dekavil
Dodekin
Onco IX
OncoFAP
FAP-IL12
Tripokin
Press Releases & Events
Work with us
Careers
Partnering
Investors
Investor Relations
Shareholding
IPO
Press Releases
Financial Statements
Financial Calendar
Internal Dealing
Buyback
Analyst Coverage
Webinars
IR Contacts
Governance
Board of Directors
Board of Statutory Auditors
Documents & Procedures
Shareholders’ Meetings
Codice etico e Modello 231
Sustainability (ESG)
News & Events
2022
,
Investors
,
Press Releases
Il Consiglio di Amministrazione approva la posizione finanziaria netta relativa al primo trimestre 2022
May 12, 2022
More details
Last News & Events
Feb
2023
6
06 febbraio 2023 – Aggiornamento sul programma di acquisto di azioni proprie
Feb
2023
2
Philogen publishes a new study in Pharmaceutics
1
2
3
…
81
Next »
